Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Mount Everest Climbers 'Poisoned' by Guides Prompting Mass Helicopter Rescues in $20 Million Insurance Fraud Scheme, Police Say - 2Jenny & Dave Marrs Mourn Loss of Former ‘Fixer to Fabulous: Italiano’ Guest
- 3UN mission says no evidence Hezbollah rearming in southern Lebanon
- 4Down to earth Manual for A Modest Hyundai Ioniq Electric for Seniors
- 5Iranian missile hit on Ne'ot Hovav factory leads to fear of chemical leakage
- Nearly half of reindeer have been wiped out and armadillos are in Iowa. Here’s how animals are weathering warming holidays
- Bold Colors, Playful Shapes, Handmade Textures: This Mexico City Home Is 100% Joyful!
- Which Instax Camera Would it be a good idea for you to Purchase?
- January’s full wolf supermoon and the Quadrantid meteor shower will start off the new year
- Court clears Beersheba assault suspect of link to Haymanut Kasau disappearance, extends detention
- Countdown to Artemis II: What to know about NASA's moon mission
- See tonight’s solar storm unfold across the world
- Best Amusement Park Bite: What Do You Very much want to Crunch On?
- SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
